MiRXES offers complete COVID-19 testing solutions, starting from sample collection and preservation, through easy and reliable RNA extraction, to tested and proven SARS-CoV-2 RT-PCR diagnostic tests.

MiRXES has launched GASTROClear, the world's first microRNA blood test for early detection of gastric cancer, with tests for other high-incidence cancers on the way.